Rational Drug Design
Organs on a Chip: A Future of Rational Drug Design
... for drug development, organs-on-a-chip has been evaluated for many advantages and disadvantages and has shown a very wide range of applications in organ re- search and rational drug ...
7
COMPUTER AIDED DRUG DESIGN: A PARADIGM SHIFT TO RATIONAL DRUG DESIGN (A CASE STUDY OF ALZHEIMER’S DRUG INTERPIRDINE FAILURE)
... Cite This Article: Dr. Kalpana Virendra Singh, Dr. Shobha Shouche, Dr. Ramchander Merugu, and Dr. Jeeven Singh Solanki. (2017). “COMPUTER AIDED DRUG DESIGN: A PARADIGM SHIFT TO RATIONAL DRUG ...
6
Drug like filters and molecular dynamics as a tool in rational drug design: application towards bioactive analgesic peptide leads
... aided drug design ...our rational drug design approach with identification of lead moieties does not contain any of these residues and they possess the structu- ral resemblance of ...
14
Rational drug design of smaller chain peptides as cardioprotective agents: Application towards denovo strategy for drug like properties and docking studies
... our rational drug design is to predict the best novel shorter chain peptide leads for cardio protective effect from the designed set of templates with various descriptors such as Lipinski rules, ...
9
100 years of sickle cell disease research: etiology, pathophysiology and rational drug design (part 1)
... the rational drug design for SCD treatment aiming to help scientists solve the mystery of this problem and to get clear vision toward possible required therapy for ...
6
Miniaturization in Rational drug design of Pharmaceuticals – A Review
... way drug discovery is practiced within the Pharmaceutical ...Increasingly, drug developers are confronting the need to streamline their processes, improve the robustness of their screening operations and ...
5
RATIONAL DRUG DESIGN: AN INFORMATION DRIVEN APPROACH TO THE DESIGN OF AN ANTHRACYCLINE ANALOG
... increased food consumption, reduced basal metabolic rate and a decrease in lean body mass. Weight gain may be associated with reoccurring cancer in some patients. 25 Women with breast cancer who gained greater than 5.9 ...
110
The computational investigation of protein/ligand complexes: implications for rational drug design
... The percentages of conformational changes detected in apo-/apo- protein comparisons have been subtracted; positive values correspond to residues whose flexibilities in apo-[r] ...
238
Functional conservation of HIV 1 Gag: implications for rational drug design
... Results We analyzed 10862 full-length gag sequences that ful- filled the quality criteria, encompassing 8 HIV-1 group M subtypes and CRFs: A1 (n = 1648), B (n = 4131), C (n = 2780), D (n = 443), F1 (n = 35), G (n = 49), ...
11
Heuristic molecular lipophilicity potential for computer-aided rational drug design
... The molecular lipophilic index, Lhf, the molecular hydrophilic index, IfM, atomic lipophilicity indices la's, and lipophilic indices 1,'s and hydrophilic indices hSys[r] ...
263
Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery.
... The affinity of the ligand for its receptor is dictated not only by the enthalpic contribution arising from close range physical interactions (Van der Waals interaction, hydrogen bonds, ionic pairing) but also by an ...
15
Computer applications for prediction of protein–protein interactions and rational drug design
... Structure-based design of peptides that mimic structural elements of a protein–protein interface 203,205 has been widely applied for the inhibition of PPI. 155,206,207 Some examples of the so-called “interface ...
23
Rational drug design of antineoplastic agents using 3D QSAR, cheminformatic, and virtual screening approaches
... the rational design of antineoplastic drugs QSAR methods have been widely applied in medicinal chemistry in order to gain insight into the critical structural requirements for compounds to interact with the ...
35
Rational drug design of Axl tyrosine kinase type I inhibitors as promising candidates against cancer
... Therefore, we focused on crizotinib by modifying it further. The R428 analog docking resulted in four high-scoring compounds, which were further utilized for structural modifications. The structural modifications of ...
17
Rational drug-design approach supported with thermodynamic studies — a peptide leader for the efficient bi-substrate inhibitor of protein kinase CK2
... Maria Winiewska-Szajewska 1,2 , Dawid Płonka 1 , Igor Zhukov 1 & Jarosław Poznański 1 Numerous inhibitors of protein kinases act on the basis of competition, targeting the ATP binding site. In this work, we present a ...
11
A Review on Bioisosterism: A Rational Approach for Drug Design and Molecular Modification
... for drug designing have been employing from many ...novel drug molecule with improved with high efficacy, potency and undesirable side effects have been the aim of the ...the rational modification of ...
28
Rational ligand based drug design and structure activity relationship studies in the ligand binding domain of the glucocorticoid receptor ?
... utilizing rational drug-design approaches, drug discovery will remain a multidisciplinary process with diverse scientific teams working together towards a common ...a rational ...
17
Rational design of phenothiazinium derivatives and photoantimicrobial drug discovery
... potential drug candidates is an essential step in the design/development ...a design viewpoint this is often a redundant step given that differences in solvent, oxygenation and – importantly – ...
27
THE RATIONAL DRUG USE OF DENTISTS IN A UNIVERSITY HOSPITAL
... the drug information, and other factors between the dentists who did and did not receive education suggests that the period and content of RDU education is ...safe drug use of 74% of the ...
9
Pharmacogenetics: Genetic basis for rational drug therapy
... in drug metabolizing enzymes The CYP2D6 poor-hydroxylator phenotype, the so-called The major modification that takes place by the Phase I sparteine-debrisoquine allele, is caused by homozygous enzymes is the ...
10